In Brief: J&J
Executive Summary
J&J: Pays off debt incurred from acquisitions of Neutrogena and Clinical Diagnostics, J&J Chairman Ralph Larsen announces April 27 at the company's annual meeting. In fact, Larsen says, J&J's net debt is "$100 mil. lower than it was a year ago." The company indicates that it is again considering acquisitions...